Celebrating Collaborative Success With 2023 CDMOs

By Jennifer Sefakis, Sr. Director of PR and Content, MasterControl, Inc.

MasterControl celebrates the achievements of its customers honored as leading CDMOs in 2023. These organizations play a crucial role in the pharmaceutical industry, delivering innovative therapies.

The CDMO Leadership Awards recognize excellence in capabilities, compatibility, expertise, quality, reliability, and service. MasterControl customers, including Samsung Biologics, FUJIFILM Diosynth, and WuXi Biologics, have demonstrated exceptional performance in these areas.

Technology plays a vital role in driving innovation and efficiency within CDMOs. MasterControl's contract manufacturing software empowers these organizations to streamline processes, ensure quality, and maintain compliance. By digitizing operations, CDMOs can accelerate time to market, reduce errors, and enhance overall performance.

Through advanced features such as electronic batch records, quality review by exception, and automated compliance checks, MasterControl's software enables CDMOs to deliver high-quality products while meeting stringent regulatory requirements. The adoption of this technology positions CDMOs as strategic partners in the development of life-saving therapies.